SUBSCRIBE
SUBSCRIBE
News   Policy

Abbott Laboratories (JOBS) Faces New US Sales Probe, Depakote in Focus

November 9, 2009 | 
1 min read
Bookmark and Share

Reuters -- Federal officials are investigating how Abbott Laboratories Inc (ABT.N) has marketed the epilepsy drug Depakote, the company said on Friday, the latest U.S. probe of its sales practices.
Regulatory
Abbott Laboratories
MORE ON THIS TOPIC
Podcast
Pfizer’s $6B China Deal, Drug Pricing and FDA’s New COVID Vaccine Plan
May 21, 2025
 · 
2 min read
 · 
Heather McKenzie
Metal pipe with empty flange covering the end. A PVC pipe with metal joins and flanges with bolts.
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
May 21, 2025
 · 
5 min read
 · 
Michael N. Abrams
FDA
FDA’s New Risk-Based Approach to COVID-19 Vaccines Aims to Ease ‘Public Distrust’: Makary, Prasad
May 20, 2025
 · 
4 min read
 · 
Heather McKenzie
3d pharmaceutical world icon with included clipping path.
Drug pricing
New Details From Trump’s Drug Pricing Effort Put Branded Drugs in the Crosshairs
May 20, 2025
 · 
1 min read
 · 
Annalee Armstrong